Compare FTHY & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FTHY | BME |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.7M | 547.5M |
| IPO Year | N/A | 2005 |
| Metric | FTHY | BME |
|---|---|---|
| Price | $13.66 | $41.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 86.8K | 34.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.84 | $34.18 |
| 52 Week High | $14.98 | $42.74 |
| Indicator | FTHY | BME |
|---|---|---|
| Relative Strength Index (RSI) | 24.27 | 35.16 |
| Support Level | N/A | $40.55 |
| Resistance Level | $14.24 | $42.55 |
| Average True Range (ATR) | 0.11 | 0.55 |
| MACD | -0.03 | -0.14 |
| Stochastic Oscillator | 5.26 | 16.34 |
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.